(Q77434756)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9779387%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

review article

1 reference

title

Community-acquired pneumonia: epidemiology, etiology, treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9779387%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

T J Marrie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9779387%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9779387%20AND%20SRC:MED&resulttype=core&format=json

Infectious Disease Clinics of North America

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9779387%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9779387%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9779387%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

723-740

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9779387%20AND%20SRC:MED&resulttype=core&format=json

Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Etiology of community-acquired pneumonia in out-patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Chlamydia-like obligate parasite of free-living amoebae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Bottle-blowing in hospital-treated patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. The British Thoracic Society Research Committee and The Public Health Laboratory Service

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Implications for rational empiric antibiotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Economic costs of respiratory tract infections in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Pneumonia in a nursing home

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Pneumonia: the impact of antibiotic resistance on its management

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

1 reference

7 January 2021

Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Diagnostic fiberoptic bronchoscopy in patients with community-acquired pneumonia. Comparison between bronchoalveolar lavage and telescoping plugged catheter cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Can antimicrobial activity be sustained? An appraisal of orally administered drugs used for respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

The Etiology of Community-Acquired Pneumonia among Hospitalized Patients during a Chlamydia pneumoniae Epidemic in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Risk factors for pneumonia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Serological investigation of pneumonia as it presents to the physician's office

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Community-acquired pneumonia. Importance of initial noninvasive bacteriologic and radiographic investigations

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

The bacteriology of obstructive pneumonitis. A prospective study using ultrasound-guided transthoracic needle aspiration.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Risk factors for acquiring pneumococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Community-acquired pneumonia requiring hospitalization: 5-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Penicillin-resistant pneumococci--an emerging threat to successful therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

An outbreak of pneumococcal pneumonia in two men's shelters

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Respiratory syncytial virus infection in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Severe community-acquired pneumococcal pneumonia. The French Study Group of Community-Acquired Pneumonia in ICU.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Community-acquired pneumonia: impact of immune status

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Severe community-acquired pneumonia. Etiology, prognosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing home-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

The epidemiology of community-acquired pneumonia among hospitalized adults

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Israeli Adult Pneumococcal Bacteremia Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

A Three-year Study of Severe Community-acquired Pneumonia With Emphasis on Outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

An outbreak of respiratory syncytial virus pneumonia in a nursing home for the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Severe Community-acquired Pneumonia: Epidemiology and Prognostic Factors

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Factors Predisposing to Oropharyngeal Colonization with Gram-Negative Bacilli in the Aged

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970207-5

7 January 2021

10.1016/S0891-5520(05)70207-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9779387%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference